Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Lymphoid Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00016172
What this trial is testing

ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT04681105
What this trial is testing

Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies

Who this might be right for
Recurrent Acute LeukemiaRecurrent B Acute Lymphoblastic LeukemiaRecurrent Blastic Plasmacytoid Dendritic Cell Neoplasm+14 more
City of Hope Medical Center 13
Early research (Phase 1)Ended earlyNCT04844086
What this trial is testing

RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaNon-Hodgkin's Lymphoma, RelapsedNon-Hodgkin's Lymphoma Refractory+5 more
Eden BioCell Ltd. 2
Early research (Phase 1)Study completedNCT00077181
What this trial is testing

3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)+8 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Ended earlyNCT04504708
What this trial is testing

Dose-Escalation and Dose-Expansion Study of ZX-101A in Patients With Relapsed/Resistant or Refractory Advanced Hematologic Malignancies

Who this might be right for
Non-hodgkin LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Hangzhou Zenshine Pharmaceuticals Co., Ltd. 6
Not applicableStudy completedNCT01499147
What this trial is testing

Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute LeukemiaChronic Myelogenous Leukemia+8 more
University of Illinois at Chicago 100
Testing effectiveness (Phase 2)Ended earlyNCT02440685
What this trial is testing

Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors

Who this might be right for
Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellLymphoma, Follicular+18 more
Asana BioSciences 51
Testing effectiveness (Phase 2)Study completedNCT00727415
What this trial is testing

Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to Therapy

Who this might be right for
Chronic Lymphocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 42
Early research (Phase 1)Study completedNCT00443976
What this trial is testing

Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins LymphomaUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 35
Not applicableStudy completedNCT01758042
What this trial is testing

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

Who this might be right for
Chronic Kidney DiseaseAcute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)+14 more
Massachusetts General Hospital 10
Early research (Phase 1)Temporarily pausedNCT05400122
What this trial is testing

Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer

Who this might be right for
Colorectal CancerHematologic MalignancyRectum Cancer+15 more
David Wald 12
Testing effectiveness (Phase 2)Study completedNCT00095381
What this trial is testing

Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia

Who this might be right for
Leukemia, T-Cell
BioCryst Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT01618136
What this trial is testing

An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors

Who this might be right for
Malignant Solid TumourOvarian CancerTriple Negative Breast Cancer+2 more
Eisai Limited 41
Early research (Phase 1)Ended earlyNCT01029509
What this trial is testing

Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)UnknownNCT00892827
What this trial is testing

Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Advanced Refractory Chronic Lymphocytic Leukemia
Wolfson Medical Center 10
Early research (Phase 1)Study completedNCT01805375
What this trial is testing

A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies

Who this might be right for
Indolent B-cell LymphomaChronic Lymphocytic LeukaemiaWaldenström Macroglobulinaemia
Cancer Research UK 28
Testing effectiveness (Phase 2)Study completedNCT00038857
What this trial is testing

Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT03678883
What this trial is testing

9-ING-41 in Patients With Advanced Cancers

Who this might be right for
CancerPancreatic CancerSarcoma+22 more
Actuate Therapeutics Inc. 350
Early research (Phase 1)Study completedNCT00019513
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Next Page